6 Matching Annotations
  1. Last 7 days
  2. www.sciencedirect.com www.sciencedirect.com
    YTHDF2 promotes ATP synthesis and immune evasion in B cell malignancies
    1
    1. scibot 18 Dec 2024
      RRID:CVCL_1319

      DOI: 10.1016/j.cell.2024.11.007

      Resource: (ATCC Cat# CRL-3002, RRID:CVCL_1319)

      Curator: @scibot

      SciCrunch record: RRID:CVCL_1319

      What is this?
      RRID:CVCL_1319
    Visit annotations in context

    Tags

    Annotators

    URL

    sciencedirect.com/science/article/pii/S0092867424013242
  3. Apr 2023
  4. aacrjournals.org aacrjournals.org
    IOA-244 is a Non–ATP-competitive, Highly Selective, Tolerable PI3K Delta Inhibitor That Targets Solid Tumors and Breaks Immune Tolerance
    1
    1. scibot 19 Apr 2023
      CVCL_1319

      DOI: 10.1158/2767-9764.CRC-22-0477

      Resource: (ATCC Cat# CRL-3002, RRID:CVCL_1319)

      Curator: @scibot

      SciCrunch record: RRID:CVCL_1319

      What is this?
      RRID:CVCL_1319
    Visit annotations in context

    Tags

    Annotators

    URL

    aacrjournals.org/cancerrescommun/article/3/4/576/725855/IOA-244-is-a-Non-ATP-competitive-Highly-Selective
  5. Jun 2022
  6. 52.53.155.43 52.53.155.43
    mcr-21-0722-html.html
    1
    1. scibot 30 Jun 2022
      CVCL_1319

      DOI: 10.1158/1541-7786.mcr-21-0722

      Resource: (ATCC Cat# CRL-3002, RRID:CVCL_1319)

      Curator: @a5munoz

      SciCrunch record: RRID:CVCL_1319

      What is this?
      RRID:CVCL_1319
    Visit annotations in context

    Tags

    Annotators

    URL

    52.53.155.43/0fa82d330555a21aeebbf676a6ea4d128f7d181e/mcr-21-0722-html.html
  7. Jul 2021
  8. www.sciencedirect.com www.sciencedirect.com
    ORY-1001, a Potent and Selective Covalent KDM1A Inhibitor, for the Treatment of Acute Leukemia
    1
    1. scibot 27 Jul 2021
      ACC-12

      DOI: 10.1016/j.ccell.2018.02.002

      Resource: (ATCC Cat# CRL-3002, RRID:CVCL_1319)

      Curator: @Jmenke

      SciCrunch record: RRID:CVCL_1319

      What is this?
      RRIDCUR:Missing RRID:CVCL_1319
    Visit annotations in context

    Tags

    Annotators

    URL

    sciencedirect.com/science/article/pii/S1535610818300230
  9. www.sciencedirect.com www.sciencedirect.com
    ASN007 is a selective ERK1/2 inhibitor with preferential activity against RAS-and RAF-mutant tumors
    1
    1. scibot 22 Jul 2021
      RRID:CVCL_1319

      DOI: 10.1016/j.xcrm.2021.100350

      Resource: (ATCC Cat# CRL-3002, RRID:CVCL_1319)

      Curator: @scibot

      SciCrunch record: RRID:CVCL_1319

      What is this?
      RRID:CVCL_1319
    Visit annotations in context

    Tags

    Annotators

    URL

    sciencedirect.com/science/article/pii/S2666379121001993
  10. Sep 2020
  11. onlinelibrary.wiley.com onlinelibrary.wiley.com
    The impact of SAMHD1 expression and mutation status in mantle cell lymphoma: An analysis of the MCL Younger and Elderly trial
    1
    1. scibot 17 Sep 2020
      RRID:CVCL_1319

      DOI: 10.1002/ijc.33202

      Resource: (ATCC Cat# CRL-3002, RRID:CVCL_1319)

      Curator: @Naa003

      SciCrunch record: RRID:CVCL_1319

      What is this?
      RRID:CVCL_1319 RRIDCUR:Validated
    Visit annotations in context

    Tags

    Annotators

    URL

    onlinelibrary.wiley.com/doi/10.1002/ijc.33202